The AI-first primary-care startup adds Summer Health’s text-based pediatric service and a 100,000-message dataset to cover care ‘from birth through adulthood.’
The digital musculoskeletal-care company is expanding into gut health — a huge, underserved market — with plans for one combined app in 2027.
University of Pennsylvania researchers found a gum made from lablab beans sharply reduced HPV in oral samples — an early, lab-only step toward preventing HPV-linked cancers.
Yale researchers found that omega-3 and omega-6 fats can dampen natural killer cells’ tumor-fighting power in mice — via a receptor called LRP5. It’s early, and not a reason to change your diet.
Whitehead Institute scientists found polyamines act as ‘storage lockers’ for iron — and draining them could poison cancer cells with their own iron.
Adding BioLife’s cell-preservation technology to its bioprocessing tools, Repligen is betting on vertical integration as cell and gene therapies scale up.
The joint investment expands device assembly for Lilly’s KwikPen in the Cincinnati region, adding at least 400 jobs as demand for diabetes and obesity injectables surges.
A new analysis of grocery data suggests banning soda from food-assistance benefits cut soda buying — but shoppers redirected much of the money to other sugary drinks.
The company said its next-generation pyruvate kinase activator failed to show enough differentiation, ceding ground to a rival Novo Nordisk therapy.
Structure Therapeutics’ once-daily oral drug aleniglipron cut body weight by 12.1% over 36 weeks — a convenient, needle-free take on the blockbuster GLP-1 class.
A UConn project won a $500,000 grant to make low-cost DHA powder from microalgae grown on brewery waste, targeting a key nutrient gap for pregnant women.
A $200 million trim to sales guidance and signs that an early demand surge had normalized wiped out roughly $12 billion in market value, as competition in the heart-disease market intensifies.